Stan Verlinden

Stan joined atai Life Sciences in 2021. Previously, Stan was an Associate in the Life Sciences & Healthcare Investment Banking team at Kempen & Co, where he worked on numerous equity capital markets transactions, M&A transactions and private fundraises for innovative biotechnology and diagnostics firms.
Prior to that, he worked at PharmaVentures, an Oxford-based life sciences financial advisory boutique specialized in licensing and M&A transactions, as well as strategic advisory work for early-stage life sciences companies.
Stan started his professional career at Imanova (now part of Invicro), a clinical research organization specializing in sophisticated molecular imaging (PET/MRI) studies primarily for Neurology and Oncology drug development.
Stan holds a BSc. in Biopharmaceutical Sciences from Leiden University, an MSc. in International Management from ESADE, and an MSc. in Finance from Bocconi University.
<<  Back to our team